Corporate News 24-Apr-19
USFDA retains the OAI status of Indoco's Goa Plant I
Indoco Remedies announced that USFDA has retained the Official Action Initiated (OAI) status for Goa Plant - I (Finished Dosage Facility) of the company. The facility was inspected by the USFDA in January 2019.
The plant currently supplies against one approved ANDA and has four ANDAs pending for approval.
Previous News
Indoco Remedies reports consolidated net loss of Rs 9.57 crore in the September 2024 quarter
( Results - Announcements 24-Oct-24 15:29 )
Indoco Remedies gains on inking pact with Clarity Pharma
( Hot Pursuit - 03-Dec-24 10:37 )
Indoco Remedies to table results
( Corporate News - 08-May-24 15:36 )
Nifty scales above 24,350; broader market outperforms
( Market Commentary - Mid-Session 03-Dec-24 10:31 )
Indoco Remedies to discuss results
( Corporate News - 07-Oct-23 11:01 )
Indoco Remedies to convene AGM
( Corporate News - 31-Aug-23 14:05 )
Indoco Remedies to declare Quarterly Result
( Corporate News - 21-Oct-22 14:02 )
Indoco Remedies to table results
( Corporate News - 11-Jan-24 11:27 )
Indoco Remedies consolidated net profit rises 178.68% in the December 2020 quarter
( Results - Announcements 09-Feb-21 14:14 )
Indoco Remedies fixes record date for final dividend
( Market Beat - Reports 22-Aug-22 16:14 )
Volumes soar at Indoco Remedies Ltd counter
( Hot Pursuit - 01-Feb-22 14:30 )
Other Stories
IndiaMART InterMESH schedules board meeting
14-Jan-25 14:13
Bacil Pharma to discuss results
14-Jan-25 14:13
AGI Greenpac announces board meeting date
14-Jan-25 14:13
Gravita India to discuss results
14-Jan-25 14:13
IDBI Bank declare Quarterly Result
14-Jan-25 14:12
Lloyds Luxuries announces board meeting date
14-Jan-25 14:12
Parshva Enterprises to discuss results
14-Jan-25 14:12
Onix Solar Energy to convene board meeting
14-Jan-25 14:12
Vishwaraj Sugar Industries to hold board meeting
14-Jan-25 13:44
MPF Systems to convene board meeting
14-Jan-25 13:43
Back
Top
